Search
for
Sort by
Research 31–60 of 74
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Menopause and Common Dermatoses: A Systematic Review
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Semaglutide and the Skin: An Overview of Current Evidence
- Beyond hair loss: Exploring the psychiatric burden of alopecia areata in a large cohort
- 0413 IL-17 Inhibitors vs. methotrexate in preventing new-onset psoriatic arthritis in psoriasis patients: a retrospective population-level analysis
- Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: a global propensity score matched retrospective cohort study
- Celiac disease associated with alopecia areata: A multicenter case-control study
- IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY
- Androgenetic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Abstracts from the 2025 WDS Forum
- 61131 Impact of Low-Dose Oral Minoxidil on Blood Pressure in Androgenetic Alopecia Patients Concomitantly Taking Antihypertensive Medications: A Multi-Center Cohort Study
- 0415 Spironolactone treatment for dermatologic conditions and blood pressure changes in hypertensive patients on concomitant antihypertensive therapy
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study
- Abstracts from the 2024 WDS Forum - virtual option
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- 266 Exploring the bidirectional impact of gastrointestinal and rosacea treatments on comorbid patients: A multi-center health records analysis
- 44391 ICI Therapy Toxicities in Psoriasis
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- MP74-11 TRENDS IN THE PHARMACOTHERAPY OF NOCTURIA, 2016-2021: ANALYSIS OF A LARGE MULTI-INSTITUTIONAL RESEARCH NETWORK
- Alopecia Areata Associated with Dupilumab: National Database Study
- Directional Association Between Irritable Bowel Syndrome and Dermatological Disease: A Large-Scale Retrospective Study
- Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia
- 63253 A pilot study of efficacy and safety comparing 5% minoxidil emulsion and standard topical 5% minoxidil solution in the treatment of male androgenetic alopecia
- Neurological post‐acute sequelae of SARS‐CoV‐2 infection
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- No association between low-dose oral minoxidil and tachycardia in a large retrospective cohort study of patients with non-scarring alopecia
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?